A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline Vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-Abdominal Infection

Trial Profile

A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline Vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-Abdominal Infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2013

At a glance

  • Drugs Ceftriaxone; Metronidazole; Tigecycline
  • Indications Bacterial infections; Intra-abdominal infections
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Aug 2010 Results have been published in Clinical Microbiology and Infection.
    • 16 Jun 2009 Actual patient number (467) added as reported by ClinicalTrials.gov.
    • 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top